Cargando…
Design and Analysis of Cancer Clinical Trials for Personalized Medicine
Biomarkers play a key role in the development of personalized medicine. Cancer clinical trials with biomarker should be appropriately designed and analyzed reflecting the various factors, such as the phase of trials, the type of biomarker, the study objectives, and whether the used biomarker is alre...
Autor principal: | Jung, Sin-Ho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147797/ https://www.ncbi.nlm.nih.gov/pubmed/34064394 http://dx.doi.org/10.3390/jpm11050376 |
Ejemplares similares
-
Personalized medicine enrichment design for DHA supplementation clinical trial
por: Lei, Yang, et al.
Publicado: (2017) -
Design and Analysis Methods for Trials with AI-Based Diagnostic Devices for Breast Cancer
por: Liu, Lu, et al.
Publicado: (2021) -
Clinical trial design in the era of precision medicine
por: Fountzilas, Elena, et al.
Publicado: (2022) -
Sources of bias for single-arm phase II cancer clinical trials
por: Jung, Sin-Ho
Publicado: (2022) -
Statistical Issues in the Design and Analysis of nCounter Projects
por: Jung, Sin-Ho, et al.
Publicado: (2014)